Clinical Partners Limited, a leading provider of mental health treatment, has successfully acquired the Oxford ADHD & Autism Centre, further strengthening its position in neurodevelopmental and mental health services.
As one of the UK’s largest independent providers in this field, Clinical Partners serves both the NHS and private sectors, catering to approximately 40,000 patients annually. With a workforce exceeding 400 employees nationwide, the company’s rapid growth reflects its commitment to broadening its reach and providing support to as many individuals as possible.
Established in 2015 by Dr Polly Branney, the Oxford ADHD & Autism Centre specialises in the diagnosis and support of children and adults with neurodevelopmental disorders and related conditions. The clinic has developed a strong reputation for delivering high-quality services in the Oxford area. Following the acquisition, the clinic’s team of around 40 specialists will join Clinical Partners.
Dr Alice Parshall, Chief Medical Officer of Clinical Partners, expressed her delight at welcoming the colleagues from the Oxford ADHD Centre. She acknowledged the clinic’s trusted reputation and commitment to delivering safe and effective services. Dr Parshall looks forward to collaborating with the team and utilising their combined experience and expertise to further enhance the range of services available to patients and families.
Dr Polly Branney shared her perspective on the acquisition, stating, “Eight years ago, I founded the clinic in response to a significant gap in local provision for autism and ADHD referrals. Since then, we have provided treatment to over 3,000 patients and partnered with various NHS services to ensure that adults and children have access to expert support.”
Recognising the rising demand and the need for growth and training, Dr Branney highlighted the decision to join a larger group organisation that can provide the necessary investment. Clinical Partners proved to be the perfect fit, aligning with the clinic’s goals. Dr Branney extended her best wishes to everyone involved as they embark on the next chapter of Oxford ADHD’s mission.
The acquisition of the entire share capital of Oxford ADHD by Clinical Partners was successfully completed on June 20, 2023, for an undisclosed sum. CapEQ (M&A) advised Oxford ADHD, with legal counsel from Freeths, while Keystone Law provided legal advice to Clinical Partners.
Mark Sapsford, Director at CapEQ, expressed pride in facilitating the transaction, recognising the critical importance of access to mental health support in today’s world. He extended well wishes to both parties, confident that their combined efforts would provide even more effective support and treatment in the Thames Valley and beyond.
Malin Svanberg Larsson, partner at Freeths, expressed delight in supporting Polly and the Oxford ADHD team throughout the transaction. She wished both Clinical Partners and Oxford ADHD success as they continued to deliver invaluable mental health support to patients across the NHS and private sector.
